Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.

Literature DB >> 27987235

ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.

Cornelis Blauwendraat¹, Mike A Nalls^2,3, Monica Federoff², Olga Pletnikova³, Jinhui Ding², Christopher Letson², Joshua T Geiger¹, J Raphael Gibbs², Dena G Hernandez^2,4, Juan C Troncoso⁵, Javier Simón-Sánchez^4,6, Sonja W Scholz^1,7.

Abstract

Entities: Chemical Disease Gene Mutation

Keywords: ADORA1; PARK16; Parkinson's disease; dementia with Lewy bodies

Mesh：

Substances：
Receptor, Adenosine A1

Year: 2016 PMID： 27987235 PMCID： PMC5318291 DOI： 10.1002/mds.26886

Source DB: PubMed Journal: Mov Disord ISSN： 0885-3185 Impact factor: 10.338

× No keyword cloud information.

5 in total

Review 1. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

Authors: Trevor W Stone; Stefania Ceruti; Mariapia P Abbracchio
Journal: Handb Exp Pharmacol Date: 2009

Review 2. Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction.

Authors: Elham Jaberi; Mohammad Rohani; Gholam Ali Shahidi; Shahriar Nafissi; Ehsan Arefian; Masoud Soleimani; Abolfazl Moghadam; Mohsen Karimi Arzenani; Farid Keramatian; Brandy Klotzle; Jian-Bing Fan; Casey Turk; Frank Steemers; Elahe Elahi
Journal: Mov Disord Date: 2016-05-02 Impact factor: 10.338

Review 3. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.

Authors: R Franco; S Ferré; L Agnati; M Torvinen; S Ginés; J Hillion; V Casadó; P Lledó; M Zoli; C Lluis; K Fuxe
Journal: Neuropsychopharmacology Date: 2000-10 Impact factor: 7.853

4. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.

Authors: Joshua T Geiger; Jinhui Ding; Barbara Crain; Olga Pletnikova; Christopher Letson; Ted M Dawson; Liana S Rosenthal; Alexander Pantelyat; J Raphael Gibbs; Marilyn S Albert; Dena G Hernandez; Argye E Hillis; David J Stone; Andrew B Singleton; John A Hardy; Juan C Troncoso; Sonja W Scholz
Journal: Neurobiol Dis Date: 2016-06-14 Impact factor: 5.996

5. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

Authors: Mike A Nalls; Nathan Pankratz; Christina M Lill; Chuong B Do; Dena G Hernandez; Mohamad Saad; Anita L DeStefano; Eleanna Kara; Jose Bras; Manu Sharma; Claudia Schulte; Margaux F Keller; Sampath Arepalli; Christopher Letson; Connor Edsall; Hreinn Stefansson; Xinmin Liu; Hannah Pliner; Joseph H Lee; Rong Cheng; M Arfan Ikram; John P A Ioannidis; Georgios M Hadjigeorgiou; Joshua C Bis; Maria Martinez; Joel S Perlmutter; Alison Goate; Karen Marder; Brian Fiske; Margaret Sutherland; Georgia Xiromerisiou; Richard H Myers; Lorraine N Clark; Kari Stefansson; John A Hardy; Peter Heutink; Honglei Chen; Nicholas W Wood; Henry Houlden; Haydeh Payami; Alexis Brice; William K Scott; Thomas Gasser; Lars Bertram; Nicholas Eriksson; Tatiana Foroud; Andrew B Singleton
Journal: Nat Genet Date: 2014-07-27 Impact factor: 38.330

5 in total

1. Functional Impact of the G279S Substitution in the Adenosine A₁-Receptor (A₁R-G279S^7.44), a Mutation Associated with Parkinson's Disease.

Authors: Shahrooz Nasrollahi-Shirazi; Daniel Szöllösi; Qiong Yang; Edin Muratspahic; Ali El-Kasaby; Sonja Sucic; Thomas Stockner; Christian Nanoff; Michael Freissmuth
Journal: Mol Pharmacol Date: 2020-09 Impact factor: 4.436

2. Adenosine A₁ and A_2A receptors are involved on guanosine protective effects against oxidative burst and mitochondrial dysfunction induced by 6-OHDA in striatal slices.

Authors: C M Massari; L C Constantino; C I Tasca
Journal: Purinergic Signal Date: 2021-02-06 Impact factor: 3.765

ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.

Review 1. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

Review 2. Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction.

Review 3. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.

4. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.

5. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

1. Functional Impact of the G279S Substitution in the Adenosine A₁-Receptor (A₁R-G279S^7.44), a Mutation Associated with Parkinson's Disease.

2. Adenosine A₁ and A_2A receptors are involved on guanosine protective effects against oxidative burst and mitochondrial dysfunction induced by 6-OHDA in striatal slices.

Review 3. The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions.

4. Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps.

5. Adenosine A₁-A_2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease.

ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.

Review 1. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

Review 2. Mutation in ADORA1 identified as likely cause of early-onset parkinsonism and cognitive dysfunction.

Review 3. Evidence for adenosine/dopamine receptor interactions: indications for heteromerization.

4. Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies.

5. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease.

1. Functional Impact of the G279S Substitution in the Adenosine A1-Receptor (A1R-G279S7.44), a Mutation Associated with Parkinson's Disease.

2. Adenosine A1 and A2A receptors are involved on guanosine protective effects against oxidative burst and mitochondrial dysfunction induced by 6-OHDA in striatal slices.

Review 3. The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions.

4. Ten Years of the International Parkinson Disease Genomics Consortium: Progress and Next Steps.

5. Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease.

1. Functional Impact of the G279S Substitution in the Adenosine A₁-Receptor (A₁R-G279S^7.44), a Mutation Associated with Parkinson's Disease.

2. Adenosine A₁ and A_2A receptors are involved on guanosine protective effects against oxidative burst and mitochondrial dysfunction induced by 6-OHDA in striatal slices.

5. Adenosine A₁-A_2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease.